Dr. Davila and the staff of Awakenings KC attended The Clinical TMS Society conference. Where they learned from leading TMS researchers and clinicians. Dr. Davila and team presented to the conference their clinical results and research done by the practice.
Davila M.C., Ely, B., & Manzardo, A.M. (2019). Relationship between body
mass and clinical response to repetitive transcranial magnetic
stimulation (rTMS) for major depressive disorder. Mental Illness,
11(1):8116. http://doi.org/10.4081/mi.2019
Davila, M. C., Ely, B., & Manzardo, A. M. (2019). Repetitive
transcranial magnetic stimulation (rTMS) using different TMS instruments
for major depressive disorder at a suburban tertiary clinic. Mental
illness, 11(1), 7947. https://doi.org/10.4081/mi.201
Manzardo, A.M., Ely, B., & Davila, M.C.(2019). Time to remission
analysis for major depressive disorder after repetitive transcranial
magnetic stimulation (rTMS). Mental Illness, 11(1):8141.
http://doi.org/10.4081/mi.2019
Dr. Davila and the Staff of Awakenings KC has presented CEU’s to over 400 Mental Health professionals in the KC Metro Area. Topics discussed included
Click Here to learn more our next CEU
10 M.D. Residents
2 M.D. Fellows
Dr. Edwin A Salsitz, DFASAM, is the chair and presenter for the ASAM ER/LA Opioid REMS course. Led by Dr. Salsitz, the course provided information to medical professionals about handling the Opioid Epidemic. Click Here to learn more about the ASAM ER/LA Opioid REMS course
The Annual meeting of the Clinical TMS Society provides a unique opportunity for you to connect with an international gathering of TMS providers and researchers. Dr. Davila is pictured with Dr. Mark George, led research that allowed TMS to be FDA approved for MDD. Click Here to learn more about the Clinical TMS Society.
Dr. Davila went to Harvard to receive continued training for noninvasive brain stimulation for treatment of neuropsychiatric disorders such as depression and schizophrenia, epilepsy, and chronic pain under the direction of Dr. Alvaro Pascual-Leone. Clinical work also includes studies of central motor conduction time, cortical excitability, and noninvasive cortical mapping. Click Here to learn more about BACNBS and Dr. Alvaro Pascual-Leone.
In order to fully understand TMS, Dr. Davila traveled to MUSC to visit with Dr. Mark George, who led research that allowed TMS to be FDA approved for MDD. Click Here to learn more about MUSC and the TMS Research Program.